Viewing Study NCT05297669


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
Study NCT ID: NCT05297669
Status: COMPLETED
Last Update Posted: 2023-05-22
First Post: 2022-03-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BALF-PAIN-3002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators